Insider Trading & Ownership - Townsend Richard Nolan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Townsend Richard Nolan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-11
Sale
2024-11-13
5:33 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
2,500$7.8227$19,557241,850
(Direct)
View
2024-10-10
Sale
2024-10-15
1:45 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$8.0991$40,496244,350
(Direct)
View
2024-09-10
Sale
2024-09-11
5:17 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$10.65$53,274249,350
(Direct)
View
2024-08-12
Sale
2024-08-13
6:34 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$11.53$57,635254,350
(Direct)
View
2024-07-10
Sale
2024-07-12
4:55 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
55,000$16.79$923,388259,350
(Direct)
View
2024-06-10
Sale
2024-06-12
5:00 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$17.65$88,264314,350
(Direct)
View
2024-05-13
Sale
2024-05-14
4:04 pm
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$13.22$66,093319,350
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-11
Exercise
2024-11-13
5:33 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
2,500$2.33241,850
(Direct)
View
2024-11-11
Exercise
2024-11-13
5:33 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
2,500$0241,850
(Direct)
View
2024-10-10
Exercise
2024-10-15
1:45 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33244,350
(Direct)
View
2024-10-10
Exercise
2024-10-15
1:45 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0244,350
(Direct)
View
2024-09-10
Exercise
2024-09-11
5:17 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33249,350
(Direct)
View
2024-09-10
Exercise
2024-09-11
5:17 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0249,350
(Direct)
View
2024-08-12
Exercise
2024-08-13
6:34 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33254,350
(Direct)
View
2024-08-12
Exercise
2024-08-13
6:34 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0254,350
(Direct)
View
2024-07-10
Exercise
2024-07-12
4:55 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33259,350
(Direct)
View
2024-07-10
Exercise
2024-07-12
4:55 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0259,350
(Direct)
View
2024-06-10
Exercise
2024-06-12
5:00 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33314,350
(Direct)
View
2024-06-10
Exercise
2024-06-12
5:00 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$0314,350
(Direct)
View
2024-05-13
Exercise
2024-05-14
4:04 pm
N/A
2031-02-15
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
5,000$2.33319,350
(Direct)
View
2024-01-05
Option Award
2024-01-09
6:52 pm
N/A
2034-01-04
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
306,250$0433,195
(Direct)
View

Ownership
2023-11-02
9:42 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOTownsend Richard Nolan
Chief Executive Officer
0$0906,222
(Direct)
View